4//SEC Filing
HSIAO JANE PH D 4
Accession 0001209191-23-009337
CIK 0000944809other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:06 PM ET
Size
8.6 KB
Accession
0001209191-23-009337
Insider Transaction Report
Form 4
HSIAO JANE PH D
DirectorVice Chairman and CTO10% Owner
Transactions
- Disposition to Issuer
5% Convertible Promissory Notes due 2023
2023-02-10$5000000.00/shExercise: $5.00Exp: 2023-02-27→ Common Stock - Award
5% Convertible Promissory Notes due 2025
2023-02-10$5000000.00/shExercise: $1.66Exp: 2025-01-31→ Common Stock
Footnotes (1)
- [F1]The two reported transactions involved an amendment and restatement of an outstanding convertible promissory note (the "Original Note"), resulting in the deemed cancellation of the Original Note and the execution of an amended note (the "Amended Note"). The Original Note was entered into on February 27, 2018 and the Reporting Person had the option to convert all or any portion of the outstanding principal balance of the Original Note, plus unpaid interest, into shares of the Issuer's common stock, par value $0.01 per share, at a conversion price of $5.00 per share, at any time prior to the maturity date, which was February 27, 2023. The Amended Note extends the maturity to January 31, 2025, and resets the conversion price to the 10 day volume weighted average price immediately preceding the date of the Amended Note, plus a 25% conversion premium, or $1.66.
Documents
Issuer
OPKO HEALTH, INC.
CIK 0000944809
Entity typeother
Related Parties
1- filerCIK 0001188834
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 6:06 PM ET
- Size
- 8.6 KB